Validation of a DNA Methylation Signature of Favorable Prognosis in Newly Diagnosed Acute Myeloid Leukemia.

被引：0

作者：

Taby, Rodolphe F. ^{[1
]}

Yellapragada, Sarvari Venkata ^{[2
,3
]}

Kroeger, Heike ^{[1
]}

He, Rong ^{[1
]}

Kornblau, Steven M. ^{[4
]}

Kantarjian, Hagop ^{[1
]}

Ravandi, Farhad ^{[1
]}

Jelinek, Jaroslav ^{[1
]}

Issa, Jean-Pierre J. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] Michael E DeBakey VA Med Ctr, Dept Hematol Oncol, Houston, TX USA

[3] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：645 / 645

页数：1

共 50 条

[21] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
Patrick K. Reville
Tapan Kadia
Current Treatment Options in Oncology, 2020, 21
[22] Validation of DNA Methylation to Predict Outcome in Acute Myeloid Leukemia by Use of xMELP
Wertheim, Gerald B. W.
Smith, Catherine
Luskin, Marlise
Rager, Alison
Figueroa, Maria E.
Carroll, Martin
Master, Stephen R.
CLINICAL CHEMISTRY, 2015, 61 (01) : 249 - 258
[23] Cyclin-dependent kinase 6 body methylation and association with prognosis of patients with acute myeloid leukemia.
Zhang, Lei
Ma, Rui
Yu, Qingxiang
Sun, Lihua
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19000 - E19000
[24] A DNA Damage Response Related Signature to Predict Prognosis in Patients with Acute Myeloid Leukemia
Wang, Jun
Wu, Jiafei
Wang, Yijing
Wang, Yu
Jiang, Chuanyan
Zou, Mengying
Jin, Xiaokang
Sun, Xiaoran
Zhang, Yu
Ma, Sijia
Wang, Guoqiang
Zhu, Xin
Lu, Huafei
Xu, Chunwei
Wang, Wenxian
Li, Leo
Han, Yusheng
Cai, Shangli
Li, Hui
CANCER INVESTIGATION, 2023, 41 (03) : 271 - 283
[25] Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia
Chen, Miao
Tao, Yuan
Yue, Pengjie
Guo, Feng
Yan, Xiaojing
BMC GENOMIC DATA, 2022, 23 (01):
[26] Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia
Miao Chen
Yuan Tao
Pengjie Yue
Feng Guo
Xiaojing Yan
BMC Genomic Data, 23
[27] Relationship between DNA index and cellular drug resistance in children with newly diagnosed acute lymphoblastic leukemia.
Karakas, Z
Gokce, S
Kuruca, SE
Demirel, GY
Ozbek, U
Akcay, A
Aydogan, G
Devecioglu, O
BLOOD, 2004, 104 (11) : 177B - 177B
[28] Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
Gibson, Amber
Dickson, Samantha
McCall, David
Garcia, Miriam
Connors, Jeremy
He, Jiasen
Roth, Michael
Nunez, Cesar
Cuglievan, Branko
PEDIATRIC BLOOD & CANCER, 2024,
[29] Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia
Ritchie, Ellen K.
Feldman, Eric J.
Christos, Paul J.
Rohan, Sarah D.
Lagassa, Catherine B.
Ippoliti, Cindy
Scandura, Joseph M.
Carlson, Karen
Roboz, Gail J.
LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2003 - 2007
[30] Retinal abnormalities in newly diagnosed adult acute myeloid leukemia
Specchia, G
Albano, F
Guerriero, S
Buquicchio, C
Pomes, L
Pastore, D
Carluccio, P
Delle Noci, N
Liso, V
ACTA HAEMATOLOGICA, 2001, 105 (04) : 197 - 203

← 1 2 3 4 5 →